QurAlis is developing precision therapeutics for ALS, a terminal disease that causes muscle paralysis through degeneration of the motor system. They are digging deep into the root causes of the multiple sub-forms of this destructive disease and focus their programs on tackling specific disease-causi... Read more
Alexion Pharmaceuticals
56 followers
Intellia Therapeutics
11 followers
Mineralys Therapeutics
3 followers
Immunome
2 followers
OneSkin
2 followers
Azenta Life Sciences
4 followers
Avidity
4 followers
Cogent Biosciences
1 follower
Odyssey Therapeutics
4 followers
Centessa Pharmaceuticals
3 followers
Johnson & Johnson
671 followers
Vaxcyte
5 followers